Tags

Type your tag names separated by a space and hit enter

Subdural hematoma in patients with end-stage renal disease receiving hemodialysis.
Eur J Neurol. 2014 Jun; 21(6):894-900.EJ

Abstract

BACKGROUND AND PURPOSE

Hemodialysis (HD) may increase the risk of acute subdural hematoma (SDH) with high fatality, but the extent of this disease in non-western populations is unclear. The incidence of and fatality from SDH in patients with end-stage renal disease (ESRD) on HD were examined for an Asian population.

METHODS

A cohort of 4709 newly diagnosed ESRD patients on HD from 1998 to 2010 and a control cohort of 18 663 subjects without any kidney disease were identified from a universal insurance claims database in Taiwan. The incidence and hazard of SDH for the two cohorts and 30-day mortality from SDH were measured by the end of 2010.

RESULTS

The incidence of SDH was 4.47-fold higher in the HD cohort than in the control cohort (56.3 vs. 12.6 per 10 000 person-years) with an adjusted hazard ratio (HR) of 3.81 (95% CI 2.77-5.25). HD patients with SDH had a high odds of 30-day mortality with an adjusted odds ratio of 6.34 (95% CI 2.37-16.9).

CONCLUSIONS

ESRD patients with HD were demonstrated to be at high risk of subsequent SDH and to have a high mortality risk from SDH. Proper care for HD patients is necessary to prevent the devastating disorder.

Authors+Show Affiliations

Graduate Institute of Clinical Medical Science, China Medical University College of Medicine, Taichung, Taiwan; Department of Internal Medicine, China Medical University College of Medicine, Taichung, Taiwan; Division of Nephrology, China Medical University Hospital, Taichung, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

24689932

Citation

Wang, I-K, et al. "Subdural Hematoma in Patients With End-stage Renal Disease Receiving Hemodialysis." European Journal of Neurology, vol. 21, no. 6, 2014, pp. 894-900.
Wang IK, Lin CL, Wu YY, et al. Subdural hematoma in patients with end-stage renal disease receiving hemodialysis. Eur J Neurol. 2014;21(6):894-900.
Wang, I. K., Lin, C. L., Wu, Y. Y., Kuo, H. L., Lin, S. Y., Chang, C. T., Yen, T. H., Chuang, F. R., Cheng, Y. K., Huang, C. C., & Sung, F. C. (2014). Subdural hematoma in patients with end-stage renal disease receiving hemodialysis. European Journal of Neurology, 21(6), 894-900. https://doi.org/10.1111/ene.12406
Wang IK, et al. Subdural Hematoma in Patients With End-stage Renal Disease Receiving Hemodialysis. Eur J Neurol. 2014;21(6):894-900. PubMed PMID: 24689932.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Subdural hematoma in patients with end-stage renal disease receiving hemodialysis. AU - Wang,I-K, AU - Lin,C-L, AU - Wu,Y-Y, AU - Kuo,H-L, AU - Lin,S-Y, AU - Chang,C-T, AU - Yen,T-H, AU - Chuang,F-R, AU - Cheng,Y-K, AU - Huang,C-C, AU - Sung,F-C, Y1 - 2014/04/01/ PY - 2013/11/07/received PY - 2014/02/07/accepted PY - 2014/4/3/entrez PY - 2014/4/3/pubmed PY - 2014/12/30/medline KW - cohort study KW - end-stage renal disease KW - hemodialysis KW - subdural hematoma SP - 894 EP - 900 JF - European journal of neurology JO - Eur J Neurol VL - 21 IS - 6 N2 - BACKGROUND AND PURPOSE: Hemodialysis (HD) may increase the risk of acute subdural hematoma (SDH) with high fatality, but the extent of this disease in non-western populations is unclear. The incidence of and fatality from SDH in patients with end-stage renal disease (ESRD) on HD were examined for an Asian population. METHODS: A cohort of 4709 newly diagnosed ESRD patients on HD from 1998 to 2010 and a control cohort of 18 663 subjects without any kidney disease were identified from a universal insurance claims database in Taiwan. The incidence and hazard of SDH for the two cohorts and 30-day mortality from SDH were measured by the end of 2010. RESULTS: The incidence of SDH was 4.47-fold higher in the HD cohort than in the control cohort (56.3 vs. 12.6 per 10 000 person-years) with an adjusted hazard ratio (HR) of 3.81 (95% CI 2.77-5.25). HD patients with SDH had a high odds of 30-day mortality with an adjusted odds ratio of 6.34 (95% CI 2.37-16.9). CONCLUSIONS: ESRD patients with HD were demonstrated to be at high risk of subsequent SDH and to have a high mortality risk from SDH. Proper care for HD patients is necessary to prevent the devastating disorder. SN - 1468-1331 UR - https://www.unboundmedicine.com/medline/citation/24689932/Subdural_hematoma_in_patients_with_end_stage_renal_disease_receiving_hemodialysis_ L2 - https://doi.org/10.1111/ene.12406 DB - PRIME DP - Unbound Medicine ER -